secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tonix Pharmaceuticals Holding Corp. (TNXP)
CIK:        0001430306
Form:       8-K
Filed at:   2026-03-18T23:59:59+00:00
Accession:  0001999371-26-006169
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tonix Pharmaceuticals dismisses EisnerAmper, appoints PwC as new auditor
------------------------------------------------------------------------

- Dismissed EisnerAmper on March 16, 2026; no disagreements on accounting principles or practices.
- Audit reports for FY2024 and FY2025 had going-concern paragraph due to losses and negative cash flows.
- Prior material weaknesses (complex transactions, inventory, warrants) were remediated by end of 2024; no restatements.
- Appointed PricewaterhouseCoopers LLP as independent auditor for FY2026, effective March 16, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1430306/000199937126006169/0001999371-26-006169-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1430306/000199937126006169/tonix-8k_031826.htm
  HTML page:      https://secwatch.observer/filing/0001999371-26-006169

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer